Moderna, NIH Advance Coronavirus Vaccine Trials
Summary from the AllSides News Team
Featured Coverage of this Story
From the Left
Late-stage clinical trial for Moderna’s COVID-19 vaccine is launched at Brigham and Women’s
A nationwide study begins Monday to find out if a potential coronavirus vaccine, developed by Cambridge-based Moderna and the National Institute of Allergy and Infectious Diseases, is safe and effective in preventing people from getting COVID-19.
The clinical trial will enroll 30,000 people, with Brigham and Women’s Hospital leading the New England section of the trial.
The Moderna vaccine is one of five candidates that have advanced to Phase 3, the stage of research in which large numbers of people get either the vaccine or a placebo and are then...
From the Center
How to volunteer for a coronavirus vaccine trial
If you're actively searching for a way to constructively contribute to the resolution of the coronavirus pandemic, you could consider volunteering for a coronavirus vaccine study. By taking part in a vaccine trial, you'd be a major player in moving science forward so the world can finally get a grip on the virus that's been overloading hospitals, taking lives and forcing lockdowns for more than six months now.
With more than 10 million cases worldwide and more than half a million deaths, it's clear that we need an intervention....
From the Right
Moderna Funding Nears $1 Billion as Vaccine Study Starts
Moderna Inc. climbed as much as 11% Monday after getting a second round of U.S. funding for an experimental vaccine for COVID-19 and kicking off its late-stage trial.
With an additional $472 million award from the Biomedical Advanced Research and Development Authority (BARDA) announced on Sunday, Moderna’s shot is now backed by $955 million of funds from the U.S.
The first participants in the 30,000 person study have been dosed, the Cambridge, Mass-based biotech company said on Monday. Earlier, it said that the new award closed a funding gap in...
AllSides Picks
April 19th, 2024
April 19th, 2024
April 19th, 2024
More News about Coronavirus from the Left, Center and Right
From the Left
From the Center
From the Right
